Press Releases

11-19 Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference AQ
25-10-30 Bausch: Q3 Earnings Snapshot AQ
25-09-08 Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage Non-Surgical System AQ
25-09-01 Bausch Health Launches YUN Probiotherapy ACN Skincare Line in Poland AQ
25-08-27 Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025 AQ
25-07-30 Bausch: Q2 Earnings Snapshot AQ
25-07-28 Bausch Health Announces the Appointment of Two New Members to Its Board of Directors AQ
25-07-07 Bausch Health : Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh “I Wish I Knew” Campaign to Educate People About Xifaxan® (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence PU
25-06-23 Bausch Health : Partners with YUN to Bring Pioneering Microbiome Skincare to Poland (English) PU
25-04-30 Bausch: Q1 Earnings Snapshot AQ
25-04-30 Bausch Health : First-Quarter 2025 Earnings Presentation PU
25-04-25 Bausch Health : Announces Launch of Solta Medical’s Fraxel FTX™ PU
25-04-10 Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris AQ
25-03-24 Bausch Health Announces Conditional Redemption of Senior Notes AQ
25-03-20 Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes AQ
25-03-19 Bausch Health : Announces Launch of Syndication of New Senior Secured Credit Facilities PU
25-02-19 Bausch Health : Fourth Quarter and Full Year 2024 Earnings Presentation PU
25-02-19 Bausch: Q4 Earnings Snapshot AQ
25-02-17 Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference AQ
25-01-20 Bausch Health Statement on Selection of XIFAXAN for Inflation Reduction Act's Medicare Negotiation Program AQ
24-12-12 Bausch + Lomb exploring several options including a potential sale AQ
24-12-03 Bausch Health Appoints New Chief Medical Officer and Head of R&D AQ
24-10-30 Bausch: Q3 Earnings Snapshot AQ
24-10-30 BAUSCH HEALTH : ANNOUNCES THIRD QUARTER 2024 RESULTS Form 8 K PU
24-10-30 Bausch Health : Third-Quarter 2024 Earnings Presentation PU
No results for this search